As shown in Fig. 1c, SLC39A4 expression is also markedly higher in stage III-IV cancers than in stage I-II counterparts (Z = 2.97, P < 0.003), indicating that SLC39A4 expression is associated with NSCLC progression. This evidence concerns the gene SLC39A4 and cancer.